AXL and glioblastoma: According to that, many clinical trials evaluating small molecule inhibitors of AXL in the treatment of recurrent glioblastoma have been registered on clinicaltrials.gov and are currently underway, as well, many combined treatments of anti-TAM therapy and other immunotherapeutic have been carried out [70].